Immediate-type infliximab infusion reaction presenting as purpura

Immediate-type infliximab infusion reactions occur during or within 1 to 2 hours of an infusion and are well documented in the literature. The most common dermatologic manifestations of immediate-type infusion reactions include urticaria and erythematous rashes. We describe the case of an immediate-type infliximab infusion reaction presenting as purpura.